Fecal immunochemical test screening may impact colorectal cancer surgery rates
the ONA take:
Screening based on fecal immunochemical testing (FIT) may have an impact on both proximal and distal colorectal cancer (CRC) surgery rates, according to an Italian study published online ahead of print inCancer.
Researchers led by Ugo Fedeli, MD, of the Regional Epidemiological Department categorized patients with CRC in the Veneto region of Italy based on staggered introduction of FIT-based screening programs: early (2002 to 2004), intermediate (2005 to 2007), and late (2008 to 2009).
Proximal and distal CRC surgery rates were investigated in these three populations between 2001 and 2012 through Joinpoint regression analysis and segmented Poisson regression models.
The researchers found that impact of screening was similar in study populations. Distal CRC surgical resection rates were found to be stable before screening, increased at time of screening implementation, and declined afterward by 10 percent annually.
Proximal CRC surgical resection rates increased by four percent annually before screening, but after a peak with screening initiation had reversed thereafter. In addition, the percentage represented by proximal CRC surgery rose from 28 percent in 2001 to 41 percent in 2012.They concluded that their “findings across each time series demonstrated that FIT-based screening programs have an impact on proximal and distal CRC surgery rates. “ However, they also noted that “underlying preexisting epidemiological trends are leading to a rapidly increasing percentage of proximal CRC.”
Screening based on fecal immunochemical testing (FIT) may have an impact on both proximal and distal colorectal cancer (CRC) surgery rates.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|